Overview
Lung Cancer
1.Role of molecular markers in the prognosis and therapy of lung cancer
2.Genomic analysis lung cancer mutations
Esophageal Cancer
1.Role of molecular markers in the prognosis and therapy of esophageal cancer
2.Genomic analysis esophageal cancer mutations
1.Role of molecular markers in the prognosis and therapy of lung cancer
2.Genomic analysis lung cancer mutations
Esophageal Cancer
1.Role of molecular markers in the prognosis and therapy of esophageal cancer
2.Genomic analysis esophageal cancer mutations
Current Appointments & Affiliations
Gary Hock Distinguished Professor of Surgery
·
2013 - Present
Surgery, Cardiovascular and Thoracic Surgery,
Surgery
Professor of Surgery
·
2007 - Present
Surgery, Cardiovascular and Thoracic Surgery,
Surgery
Member of the Duke Cancer Institute
·
2012 - Present
Duke Cancer Institute,
Institutes and Centers
Recent Publications
The 2026 American Association for Thoracic Surgery Expert Consensus Document: Evaluation and management of N2+ non-small cell lung cancer.
Journal Article J Thorac Cardiovasc Surg · May 2, 2026 OBJECTIVE: Multimodal therapy is recommended for the optimal treatment of N2 positive non-small cell lung cancer (NSCLC). Recent advancements in the use of immune checkpoint inhibitors and targeted therapy have dramatically changed the landscape of treatme ... Full text Link to item CitePembrolizumab, Radiotherapy, and Chemotherapy in Neoadjuvant Treatment of Malignant Esophago-gastric Diseases (PROCEED): A single-arm phase 2 trial.
Journal Article Cancer · December 15, 2025 INTRODUCTION: Esophagogastric cancers are common and carry a poor prognosis. A standard option for locally advanced disease has been neoadjuvant chemoradiation (CRT) followed by surgical resection. The primary goal of this study was to investigate whether ... Full text Link to item CiteRetrospective Analysis of 124 LCNEC Tumors With Targeted Expression Profiling of 111 Samples Identifies Candidate Chemo-Sensitivity Biomarker
Conference JOURNAL OF THORACIC ONCOLOGY · October 2025 Link to item CiteRecent Grants
Clinical Oncology Research Career Development Program
ResearchMentor · Awarded by National Institutes of Health · 2009 - 2015Phase I/II Trial of ZD1839 and Celecoxib in Ex-Smokers
ResearchCo Investigator · Awarded by National Institutes of Health · 2002 - 2007Genetics, Inflammation & Post-op Cognitive Dysfunction
ResearchCo Investigator · Awarded by National Institutes of Health · 1999 - 2006View All Grants
Education
Columbia University ·
1987
M.D.